Serve as U.S. HCP-lead to develop clear HCP strategy, design creative campaigns, develop messaging and coordinate a customer experience that meets HCP practices/systems where they are, while overcoming barriers to treatment.
Lead marketing efforts educate and activate General nephrologists and associated HCPs for the first therapy indicated for AMR and MVI, and subsequent expansion into IgAN. In this position you will focus on leading a team for both branded and disease education initiatives, collaborating cross-functionally and across channels.
Support the design and implementation of the 3-year brand roadmap, with focus on improved education, activation and maturation of the market. By helping define and articulate clear market development and customer experience strategies this leader will also drive solutions that crosscut audiences.
Deliver a marketing plan that proactively grows product adoption and shapes the market, going beyond core marketing to include education, scientific exchange and relationship building, evidence generation, and broader engagement with the HCP ecosystem and community to impact delivery of care.
Collaborate with global partners to support the development of an overall brand identity and positioning, and be a strong US voice shaping the development of early positioning for IgAN
Collaborate with key partners in Business Intelligence and Operations to drive deep insights on targeted physician audiences
Be accountable for comprehensive assessment of competition in igAN and identification of opportunities to guide/refine the strategy amidst rapidly changing market dynamics
Build out a team of marketers to support the preparation and execution of IgAN marketing efforts
Be a core member of the US Launch Operating Team
Manage budgets and agency partners to plan
Requirements
#LI-KK1
Required Skills
Bachelor's degree required; MBA or other advance degree preferred
12+ years of commercial experience, with 8+ years of marketing or marketing adjacent experience in the pharma or biotech industry, including launch.
Familiarity and experience with US promotional regulatory guidelines and demonstrated ability to navigate MLR processes
Experience in complex/under-developed therapeutic areas; Nephrology or Immunology experience highly preferred
Experience in designing and driving omnichannel media campaigns including building media plans, analyzing data and insight to drive key choices and defining a crisp 3-year customer engagement strategy
Must exhibit strong leadership skills, ability to perform in fast paced environments and ability to influence without authority.
Strong project and vendor management track record, including resource allocation and fiscal management.
Experience leading and developing direct and matrixed teams to drive high-impact output
Ability to travel up to 25%
Preferred Skills
Field/customer-facing experience a plus
Job Level: Management
Additional Information
The base compensation range for this role is: $234,000.00-$322,000.00
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future poten
Benefits
Equity / stock optionsPerformance bonus
Additional Information
About This Role
The Senior Director of HCP Marketing (General Nephrology) will be a critical role and visible leader within the US Nephrology Franchise, leading, planning and executing sophisticated HCP activation and educational strategies for several upcoming launches. Reporting to the Head US Nephrology Marketing, the Senior Director of HCP Marketing will lead the HCP marketing team the development and execution of U.S. branded and unbranded strategies/plans to educate, activate and support nephrologist in identifying post-transplant patients with Antibody-Mediated Rejection (AMR) and Micro-Vasculature Inflammation (MVI) and ensure appropriate referrals to treatment centers; and lead the development of unbranded and branded efforts for the subsequent expansion into IgA Nephropathy (IgAN)